Pharma & Biopharma

Axolabs’ Ingo Röhl takes us back to the early days of oligonucleotides, through a pandemic, to the promise of tomorrow

Welcome to the sixth and final chapter of “So You Want to Be a Biopharmaceutical Analyst”

We asked Tadhg Devlin, Bioprocessing Trainer at NIBRT, to provide an overview on the basics of peptide mapping – a crucial quality control step

How will analytical science transform how we diagnose and treat over the next 20 years? We asked five Human Health Pioneers.

PCR-ELISA shows poor consistency in interlaboratory comparative quantification of full and empty capsids

Spatial omics, single cell analysis, and precision medicine shine at SLAS 2025

Super-resolution microscopy uncovers antibody mechanisms against cancer with molecular precision

Our 2024 Human Health Pioneers reveal the analytical frontiers in human health and disease they’re most excited about

How do people get involved in biopharma – and what keeps them there? Welcome to the first chapter of “So You Want to Be a Biopharmaceutical Analyst.”

The 2024 Power List tell us about important problems that could – and should – be tackled through interdisciplinary work